The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Bcl11a is essential for normal lymphoid development
Abstract
Bcl11a (also called Evi9) functions as a myeloid or B cell proto-oncogene in mice and humans, respectively. Here we show that Bcl11a is essential for postnatal development and normal lymphopoiesis. Bcl11a mutant embryos lack B cells and have alterations in several types of T cells. Phenotypic and expression studies show that Bcl11a functions upstream of the transcription factors Ebf1 and Pax5 in the B cell pathway. Transplantation studies show that these defects in Bcl11a mutant mice are intrinsic to fetal liver precursor cells. Mice transplanted with Bcl11a-deficient cells died from T cell leukemia derived from the host. Thus, Bcl11a may also function as a non-autonomous T cell tumor suppressor gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, its roles in other cell lineages, including B lymphocytes and the central nervous system, may present challenges (19, 20).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [19]
Citations
Cites
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,691
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Deficient T Cell Fate Specification in Mice with an Induced Inactivation of Notch1
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J. P. M., MacDonald, H. R., & Aguet, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80054-0 · Cited by 1,393
Hardy, R. R., & Hayakawa, K. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.595 · Cited by 1,236
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 351
Khan, D. M. I. O., Karmaus, P. W. F., Bach, A. P., Crawford, R. B., & Kaminski, N. E. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010169 · Cited by 22
Demirci, S., Zeng, J., Palchaudhuri, R., Wu, C., Abraham, D. M., Hayal, T. B., Essawi, K., Nguyen, M. A., Stasula, U., Chu, R., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.014 · Cited by 24
miR-146a induces apoptosis in neuroblastoma cells by targeting BCL11A
Li, S., Li, J., Chen, L., & Liu, J. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.05.019 · Cited by 22
Load and lock: the molecular mechanisms of B‐lymphocyte commitment
Zandi, S., Bryder, D., & Sigvardsson, M. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00950.x · Cited by 21
The Unsolved Puzzle of c-Rel in B Cell Lymphoma
Kober, M., & Schmidt‐Supprian, M. (2019) · Cancers · doi:10.3390/cancers11070941 · Cited by 22
BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma
Shi, H., Li, C., Feng, W., Yue, J., Song, J., Peng, A., & Wang, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00820 · Cited by 21
Expression of zinc finger transcription factor Bcl11A/Evi9/CTIP1 in rat brain
Kuo, T., & Hsueh, Y. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21300 · Cited by 21
Transcriptional control of natural killer cell differentiation and function
Martin‐Fontecha, A., Lord, G. M., & Brady, H. J. M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0800-9 · Cited by 21
CRISPR/Cas9 system and its applications in human hematopoietic cells
Hu, X. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.09.003 · Cited by 22
Ali, G., Tariq, M. A., Shahid, K., Ahmad, F. J., & Akram, J. (2020) · Gene Therapy · doi:10.1038/s41434-020-0153-9 · Cited by 20
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 21
Genomic Alterations in Hodgkin's Lymphoma
Weniger, M. A., Barth, T. F. E., & Mӧller, P. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06048 · Cited by 20
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 21
Dendritic cell functions in vivo: A user's guide to current and next‐ generation mutant mouse models
Dalod, M., & Scheu, S. (2022) · European Journal of Immunology · doi:10.1002/eji.202149513 · Cited by 19
Molecular resolution of the B cell landscape
Santos, P. M. L., & Borghesi, L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.11.014 · Cited by 19
Matsuura, T., Miyazaki, S., Miyazaki, T., Tashiro, F., & Miyazaki, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12772-y · Cited by 19
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
Chondrou, V., Stavrou, E. F., Markopoulos, G. S., Kouraklis‐Symeonidis, A., Fotopoulos, V. E., Symeonidis, A. S., Vlachaki, E., Chalkia, P., Patrinos, G. P., Papachatzopoulou, A., et al. (2018) · Human Genomics · doi:10.1186/s40246-018-0177-z · Cited by 19
BCL11A Down-Regulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells
Li, J., Yongrong, L., & Shi, L. (2018) · Hemoglobin · doi:10.1080/03630269.2018.1515774 · Cited by 18
Expression of essential B cell development genes in horses with common variable immunodeficiency
Tallmadge, R. L., Such, K., Miller, K. C., Matychak, M. B., & Felippe, M. J. B. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.018 · Cited by 18
BRAFV600E induces key features of LCH in iPSCs with cell type–specific phenotypes and drug responses
Abagnale, G., Schwentner, R., Soussia-Weiss, P. B., van Midden, W., Sturtzel, C., Pötschger, U., Radoš, M., Taschner‐Mandl, S., Simonitsch‐Klupp, I., Hafemeister, C., et al. (2024) · Blood · doi:10.1182/blood.2024026066 · Cited by 17
Recent advances in globin research using genome‐wide association studies and gene editing
Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17
The Fetal-to-Adult Hemoglobin Switch — Mechanism and Therapy
Orkin, S. H. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2405260 · Cited by 18
The Role of Bcl11 Transcription Factors in Neurodevelopmental Disorders
Seigfried, F. A., & Britsch, S. (2024) · Biology · doi:10.3390/biology13020126 · Cited by 16
Braekeleer, M. D., Tous, C., Guéganic, N., Bris, M. L., Basinko, A., Morel, F., & Douet‐Guilbert, N. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.793 · Cited by 16
Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells
Napolitano, R., Matteis, S. D., Carloni, S., Bruno, S., Abbati, G., Capelli, L., Ghetti, M., Bochicchio, A. M., Liverani, C., Mercatali, L., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7730 · Cited by 16
RetractedMolecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
Wessels, M. W., Cnossen, M. H., van Dijk, T. B., Gillemans, N., Schmidt, K. L. J., van Lom, K., Vinjamur, D. S., Coyne, S. M., Kurita, R., Nakamura, Y., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003753 · Cited by 16
Downing, J. R., & Mullighan, C. G. (2006) · Hematology · doi:10.1182/asheducation-2006.1.118 · Cited by 16
Treating Sickle Cell Disease: Gene Therapy Approaches
Cavazzana, M., Corsia, A., Brusson, M., Miccio, A., & Semeraro, M. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022124-022000 · Cited by 15
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects
George, C. A., Sahu, S. U., de Oñate, L., Souza, B. S. D. F., & Wilson, R. C. (2024) · The CRISPR Journal · doi:10.1089/crispr.2024.0036 · Cited by 15
Genetic and Epigenetic Control of Early Lymphocyte Development
Ikawa, T. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_370 · Cited by 15
Yamamoto, S., Uchida, Y., Ohtani, T., Nozaki, E., Yin, C., Gotoh, Y., Yakushiji‐Kaminatsui, N., Higashiyama, T., Suzuki, T., Takemoto, T., et al. (2019) · Development Growth & Differentiation · doi:10.1111/dgd.12601 · Cited by 15
Shin, B., & Rothenberg, E. V. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1108368 · Cited by 18
Potential DNA markers as a rapid tracing tool for animal adulterants in vegetarian food
Mi, X., Yang, J., Cao, L., Wei, X., Zhu, Y., Li, Q., Liu, X., He, X., Liao, Q., & Yan, Z. (2015) · Food Research International · doi:10.1016/j.foodres.2015.04.007 · Cited by 15
Gene Regulatory Networks Orchestrating B Cell Fate Specification, Commitment, and Differentiation
Medina, K. L., & Singh, H. (2005) · Springer eBooks · doi:10.1007/3-540-26363-2_1 · Cited by 15
GWAS to Therapy by Genome Edits?
Hardison, R. C., & Blobel, G. A. (2013) · Science · doi:10.1126/science.1245813 · Cited by 15
The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.
Zhang, N., Jiang, B., Zhang, X., Xie, Z., Su, J., Zhang, Q., Han, J.-F., Tu, H., & Wu, Y.-L. L. C. (2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.09.39 · Cited by 14
Lee, S. H. R., Qian, M., Yang, W., Diedrich, J. D., Raetz, E. A., Yang, W., Dong, Q., Devidas, M., Pei, D., Yeoh, A. E. J., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa133 · Cited by 14
Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia
Huang, X., Geng, S., Weng, J., Lu, Z., Zeng, L., Li, M., Deng, C., Wu, X., Li, Y., & Du, X. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0242-9 · Cited by 14
Transcriptional Repressor BCL11A in Erythroid Cells
Zheng, G., & Orkin, S. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_9 · Cited by 13
Lee, B.-S., Dekker, J. D., Lee, B.-K., Iyer, V. R., Sleckman, B. P., Shaffer, A. L., Ippolito, G. C., & Tucker, P. W. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00987-12 · Cited by 13
RetractedThe expression pattern of Bcl11a, Mdm2 and Pten genes in B‐cell acute lymphoblastic leukemia
Xu, L., Wu, H., Wu, X., Li, Y., & He, D. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12690 · Cited by 13
BCL11A is a SUMOylated protein and recruits SUMO‐conjugation enzymes in its nuclear body
Kuwata, T., & Nakamura, T. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01216.x · Cited by 13
Self-citationAcute mixed lineage leukemia and a t(6;14)(q25;q32) in two adults
Georgy, M., Yonescu, R., Griffin, C. A., & Batista, D. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.04.010 · Cited by 13
Establishment and Maintenance of B Cell IdentityPreprint
Grosschedl, R. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020057 · Cited by 13
Physiological and Aberrant γ-Globin Transcription During Development
Barbarani, G., Łabędź, A., Stucchi, S., Abbiati, A., & Ronchi, A. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640060 · Cited by 12
Vickridge, E., Faraco, C. C. F., Samavarchi‐Tehrani, P., Ramdzan, Z. M., Djerir, B., Rahimian, H., Leduy, L., Maréchal, A., Gingras, A., & Nepveu, A. (2022) · NAR Cancer · doi:10.1093/narcan/zcac028 · Cited by 12
C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies
Zhang, X., Xia, F., Zhang, X., Blumenthal, R., & Cheng, X. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168343 · Cited by 12
Combination of BCL11A siRNA with vincristine increases the apoptosis of SUDHL6 cells
He, D., Wu, H., Li, D., & Li, Y. (2014) · European journal of medical research · doi:10.1186/2047-783x-19-34 · Cited by 12
Okuyama, K., Yamashita, M., Koumoundourou, A., Wiegreffe, C., Ohno‐Oishi, M., Murphy, S. J. H., Zhao, X., Yoshida, H., Ebihara, T., Satoh‐Takayama, N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01997-5 · Cited by 11
Zhang, S., Fang, X., Chang, M., Zheng, M., Guo, L., Xu, Y., Shu, J., Nie, Q., & Li, Z. (2024) · BMC Genomics · doi:10.1186/s12864-024-11030-6 · Cited by 12
Yang, H. M., Zheng, G., Li, G. Y., Alshaye, A., & Orkin, S. H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108077 · Cited by 12
Wongborisuth, C., Chumchuen, S., Sripichai, O., Anurathapan, U., Sathirapongsasuti, N., Songdej, D., Tangprasittipap, A., & Hongeng, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-08920-8 · Cited by 11
Rajendiran, V., Devaraju, N., Haddad, M., Ravi, N. S., Panigrahi, L., Paul, J., Gopalakrishnan, C., Wyman, S. K., Ariudainambi, K., Mahalingam, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.023 · Cited by 12
Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment
Rahimmanesh, I., Boshtam, M., Kouhpayeh, S., Khanahmad, H., Dabiri, A., Ahangarzadeh, S., Esmaeili, Y., Bidram, E., Vaseghi, G., Javanmard, S. H., et al. (2022) · Biology · doi:10.3390/biology11060862 · Cited by 11
Kirberg, J., Gschwendner, C., Dangy, J., Rückerl, F., Frommer, F., & Bachl, J. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.11.018 · Cited by 11
Influences of Genetic Variation on Fetal Hemoglobin
He, Y., Lin, W., & Luo, J. (2011) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2011.616573 · Cited by 11
DeWitt, M. A., Magis, W., Bray, N., Wang, T., Berman, J. R., Urbinati, F., Muñoz, D. P., Kohn, D. B., Walters, M. C., Carroll, D., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/036236 · Cited by 12
Ikuta, T., Kurayanagi, Y., Odo, N., & Liu, S. M. (2013) · Journal of Blood Medicine · doi:10.2147/jbm.s54671 · Cited by 10
p53-Dependent Transcriptional Responses to Interleukin-3 Signaling
Jabbour, A. M., Gordon, L., Daunt, C. P., Green, B. D., Kok, C. H., D’Andrea, R. J., & Ekert, P. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031428 · Cited by 10
Effects of Prednisolone on Specifically Expressed Genes in Pediatric Acute B-lymphoblastic Leukemia
Akiyama, M., Yamada, O., Agawa, M., Yuza, Y., Yanagisawa, T., Eto, Y., & Yamada, H. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318161a28f · Cited by 10
Mola, S., Foisy, S., Boucher, G., Major, F., Beauchamp, C., Karaky, M., Goyette, P., Lesage, S., & Rioux, J. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233543 · Cited by 10
Innovative Therapies for Hemoglobin Disorders
Sii-Felice, K., Nègre, O., Brendel, C., Tubsuwan, A., Morel-à-l’Huissier, E., Filardo, C., & Payen, E. (2020) · BioDrugs · doi:10.1007/s40259-020-00439-6 · Cited by 10
Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in micePreprint
Araujo, A. M., Dekker, J. D., Garrison, K., Su, Z., Rhee, C., Hu, Z., Lee, B., Osorio, D., Lee, J., Iyer, V. R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/310680 · Cited by 10
Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease
Fontana, L., Martinucci, P., Amistadi, S., Félix, T., Mombled, M., Tachtsidi, A., Corre, G., Chalumeau, A., Hardouin, G., Martin, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102376 · Cited by 9
Papadopoulos, P., Kafasi, A., Cuyper, I. M. D., Barroca, V., Lewandowski, D., Kadri, Z., Veldthuis, M., Berghuis, J., Gillemans, N., Cuesta, C. B., et al. (2020) · Human Genomics · doi:10.1186/s40246-020-00283-3 · Cited by 9
Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles
Jiang, M., Zeng, Q., Dai, S., Liang, H., Dai, F., Xie, X., Lu, K., & Gao, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6021 · Cited by 9
Gene expression profile analysis of SUDHL6 cells with siRNA‐mediated BCL11A downregulation
Wu, H., Gao, Y., Ding, L., He, D., & Li, Y. (2014) · Cell Biology International · doi:10.1002/cbin.10332 · Cited by 9
Dual role of BCL11B in T-cell malignancies
Przybylski, G. K., Przybylska, J., & Li, Y. (2024) · Blood Science · doi:10.1097/bs9.0000000000000204 · Cited by 8
Gao, Y., He, D., Chen, S., Yan, X., Hu, X., & Li, Y. (2011) · Clinical Oncology and Cancer Research · doi:10.1007/s11805-011-0588-2 · Cited by 7
CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation
Papasavva, P. L., Patsali, P., Loucari, C. C., Kurita, R., Nakamura, Y., Kleanthous, M., & Lederer, C. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031082 · Cited by 7
BCL11A Expression in Breast Cancer
Kątnik, E., Gomułkiewicz, A., Piotrowska, A., Grzegrzółka, J., Rusak, A., Kmiecik, A. M., Ratajczak‐Wielgomas, K., & Dzięgiel, P. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040175 · Cited by 7
ZNF16 (HZF1) promotes erythropoiesis and megakaryocytopoiesis via regulation of the c-KIT gene
Chen, J., Li, X., Su, R. J., Song, L., Wang, F., & Zhang, J. (2013) · Biochemical Journal · doi:10.1042/bj20130628 · Cited by 8
Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell development
Shapiro, M. J., & Shapiro, V. S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.11.013 · Cited by 7
Kansal, R. (2025) · Genes · doi:10.3390/genes16111367 · Cited by 6
Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice
Araujo, A. M., Dekker, J. D., Garrison, K., Su, Z., Rhee, C., Hu, Z., Lee, B., Osorio, D., Lee, J., Iyer, V. R., et al. (2024) · eLife · doi:10.7554/elife.96394 · Cited by 6
Gnanapragasam, M. N., Planutis, A., Glassberg, J., & Bieker, J. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-34805-5 · Cited by 6
Salama, S., Hamdy, N. Μ., Elshimy, R. A. A., & EL-Mesallamy, H. O. (2021) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2021.75847.1058 · Cited by 6
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia
Ochi, Y., Liew-Littorin, M., Nannya, Y., Bengtzén, S., Piauger, B., Deneberg, S., Jädersten, M., Lazarević, V., Cammenga, J., Robelius, A., et al. (2026) · Nature · doi:10.1038/s41586-026-10703-4 · Cited by 5
Zaunz, S., Smedt, J. D., Lauwereins, L., Cleuren, L., Laffeber, C., Bajaj, M. S., Lebbink, J. H. G., Marteijn, J. A. F., Keersmaecker, K. D., & Verfaillie, C. M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10550-0 · Cited by 6
Transcriptional regulation in the development and dysfunction of neocortical projection neurons
Wang, N., Wan, R., & Tang, K. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379039 · Cited by 6
Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors
Wu, Y., Li, Y., Fu, B., Jin, L., Zheng, X., Zhang, A., Sun, R., Zhigang, T., & Wei, H. (2017) · Oncotarget · doi:10.18632/oncotarget.18659 · Cited by 5
The transcription factor Bcl11a is essential for B-1a cell maintenance during aging
Xu, S., Huang, L., Liu, X., Zhang, L., Wang, J., Hu, Y., Yang, Y., Shi, X., Liu, C., Wang, R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2501974122 · Cited by 4
Gene Therapy for Sickle Cell Anemia in India - Current Status and Challenges
Goel, A., Dalal, V., Dhawan, R., Maiti, S., & Chakraborty, D. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02105-9 · Cited by 4
Abnormalities of the structure and synthesis of hemoglobin
Thein, S. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00009-2 · Cited by 5
Matsumoto, K., Okuyama, K., Sidwell, T., Yamashita, M., Endo, T. A., Satoh‐Takayama, N., Ohno, H., Morio, T., Rothenberg, E. V., & Taniuchi, I. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1363704 · Cited by 4
Transcriptional Regulation of Early B Cell Development
Hagman, J. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00003-5 · Cited by 4
Planell, N., Martinez‐de‐Morentin, X., Mouzo, D., Lara‐Astiaso, D., Vilas‐Zornoza, A., Martín‐Úriz, P. S., Alignani, D., Paiva, B., Maillo, A., Kurowska, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw3110 · Cited by 4
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis
Zhang, H., Zeng, J., Zhang, F., Liu, J., & Liang, L. (2025) · Biology · doi:10.3390/biology14010026 · Cited by 4
Decoding transcriptional regulation via a human gene expression predictor
Wang, Y., Zhang, Y., Ning, Y., Li, B., Gong, J., Mei, Y., Bao, J., & Ma, S. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.01.006 · Cited by 3
Using mouse models to study function of transcriptional factors in T cell development
Li, P., Xiao, Y., Liu, Z., & Liu, P. (2012) · Cell Regeneration · doi:10.1186/2045-9769-1-8 · Cited by 4
Self-citationNormal and Malignant Hematopoiesis
Shah, B. D., & Zuckerman, K. S. (2011) · Wiley eBooks · doi:10.1002/9781444394016.ch1 · Cited by 3
High-efficiency HDR in immortalized cell lines by crude rAAV mediated donor template deliveryPreprint
Mehta, S., Buyanbat, A., Zheng, G., Liu, N., & Orkin, S. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.02.490359 · Cited by 3
The BCL11A transcription factor stimulates the enzymatic activities of the OGG1 DNA glycosylase
Petrachkova, T., Солдаткина, О. И., Leduy, L., & Nepveu, A. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0088 · Cited by 2
Linfopoyesis temprana en médula ósea adulta
Welner, R. S., Kincade, P. W., & Pelayo, R. (2007) · Inmunología · doi:10.1016/s0213-9626(07)70083-5 · Cited by 2
RNA Silencing: An Approach for the Treatment of β-Thalassemia
Urkude, V., & Amit, M. (2012) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000135 · Cited by 2
Modifiers of γ-Globin Gene Expression and Treatment of β-Thalassemia
Munshi, A., Dadeech, S., Babu, M. S., & Khetarpal, P. (2015) · InTech eBooks · doi:10.5772/61441 · Cited by 2
Molecular mechanisms in haematological malignancies
Grech, G., Avellino, R., & Schembri-Wismayer, P. (2009) · OAR@UM (University of Malta) · Cited by 2
BHANJA, S. K., Goel, A., Mehra, M., Bag, S., Kharche, S. D., Malakar, D., & Dash, B. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.03.027 · Cited by 2
Inherited Hemoglobin Disorders
Munshi, A. (2015) · InTech eBooks · doi:10.5772/59742 · Cited by 3
ZNF410 represses fetal globin by devoted control of CHD4/NuRDPreprint
Vinjamur, D. S., Yao, Q., Cole, M. A., McGuckin, C., Ren, C., Zeng, J., Hossain, M., Luk, K., Wolfe, S. A., Pinello, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.31.272856 · Cited by 2
Metadata
- Authors
- Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G.
- Affiliations
- National Cancer Institute (US)
- Science Applications International Corporation (United States) (US)
- Japanese Foundation For Cancer Research (JP)
- Corresponding author
- Copeland, Neal G
- Venue
- Nature Immunology
- Published
- 2003-04-28
- Volume
- 4
- Issue
- 6
- Pages
- 525-532
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1998167494
- Cited by
- 351
- References
- 51
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 21 · 2023: 14 · 2022: 14 · 2021: 19 · 2020: 16 · 2019: 15 · 2018: 14 · 2017: 13 · 2016: 26 · 2015: 19 · 2014: 15 · 2013: 24 · 2012: 17
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22)
- National Cancer Institute (N01CO12400)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Keywords
- BCL11A, lymphoid development, lymphocyte development, B cell development, T cell development, EBF1, PAX5, T-cell leukemia, tumor suppressor, proto-oncogenes, postnatal development
- MeSH terms
- Proto-Oncogene Mas, Animals, B-Lymphocytes, Carrier Proteins, DNA-Binding Proteins, Membrane Proteins, Mice, Inbred C57BL, Neoplasm Proteins, Nuclear Proteins, Receptors, Cell Surface, Repressor Proteins, Transcription Factors, Signal Transduction, Leukemia, T-Cell, Mice, Knockout, Lymphopoiesis, Mice, Receptor, Notch1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review